niacin

Browse trials
V2  
List  

treatment    comparator  All cause death Coronary death Coronary event Adverse events Cardiovascular death Death from cancer MACE Haemmorhagic stroke Fatal stroke Non fatal MI Cancer Rhabdomyolysis stroke (fatal and non fatal)  cardiac death cardiovascular events Coronary death and non fatal MI Myopathy LDL non cardiovascular death  Venous thromboembolism new-onset diabetes  total cholesterol (at 1 y) HDL (at 1 y)     
Niacincardiovascular prevention, in all type of patients vs controlNS-NS----------NSNS---NS----
Niacincardiovascular prevention, in all type of patients vs placeboNSNS by 17% --NS--- by 27% ----NS---NS----
Niacincardiovascular prevention, in all type of patients vs placebo (on top statin)NS-NS-NS-------NS-NS--------
Niacincardiovascular prevention, in all type of patients vs ezetimibe-- by 79% ----------- by 2849% --------
Niacincardiovascular prevention, in all type of patients vs simvastatin+ezetimibe--NS---------NS- by 2153% --------